论文部分内容阅读
我院近10年用川芎嗪辅助治疗55例结核性脑膜炎,疗效满意,现进行临床探讨分析如下。 资料与方法 1 一般资料 55例结核性脑膜炎治疗组28例,对照组27例。治疗组28例中,男17例、女11例;平均年龄21岁;单纯性结核性脑膜炎7例占25％、合并肺结核21例占75％;早期(<7天)无,中期(8～15天)1例占3.7％,晚期(>30天)27例占96.3％。对照组27例,男19例、女8例;年龄8～31岁,平均年龄23岁;单纯性结核性脑膜炎6例占22％,合并肺结核21例占78％;早期无,中期无,晚期27例。
In our hospital for nearly 10 years with ligustrazine adjuvant treatment of 55 cases of tuberculous meningitis, with satisfactory results, the clinical discussion is as follows. Materials and Methods 1 General Information 55 cases of tuberculous meningitis treatment group 28 cases, control group 27 cases. The treatment group of 28 patients, 17 males and 11 females; mean age 21 years; 7 cases of simple tuberculous meningitis accounted for 25%, 21 cases of tuberculosis combined accounted for 75%; early (<7 days) no, medium ~ 15 days) in 1 case accounted for 3.7%, advanced (> 30 days) 27 cases accounted for 96.3%. The control group of 27 patients, 19 males and 8 females; aged 8 to 31 years, mean age 23 years; 6 cases of simple tuberculous meningitis accounted for 22%, 21 cases of tuberculosis accounted for 78%; no early, 27 cases of advanced.